Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Use of Corticosteroid in Periarticular Injections in Primary Total Knee Arthroplasty
NCT07151417Phase 3Recruiting
- Sponsor
- Walter Reed National Military Medical Center
- Start
- Sep 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 3, randomised trial of triamcinolone acetonide in postoperative pain (3 arms), sponsored by Walter Reed National Military Medical Center. Primary endpoints: Total Knee Arthroplasty Outcomes at 28 days, Postoperative Range of Motion at 365 days and 4 more. Started Sep 2026; status: recruiting.
02
Drugs
triamcinolone acetonide
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07151417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07151417.